Consensus Molecular Subtypes Efficiently Classify Gastric Adenocarcinomas and Predict the Response to Anti-PD-1 Immunotherapy.
Xiangyan WuYuhan YeKenneth J VegaJiannan YaoPublished in: Cancers (2022)
Our study reveals the practical utility of CMS classification for GAC to improve clinical outcomes and identify candidates who will respond to immunotherapy.
Keyphrases